Showing 1,221 - 1,240 results of 1,770 for search '(( 2 d decrease ) OR ( 10 ((peter decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.16s Refine Results
  1. 1221

    Synthesis and properties of HA/ZnO/CNT nanocomposite by Ding M.

    Published 2018
    “…The goal of this study was to examine the tribomechanical properties of hydroxyapatite (HA)/ZnO and HA/ZnO/CNT composite ceramics (carbon nanotubes; with different ratios 0.5 wt%, 1.0 wt%, and 1.5 wt%). The composites were synthesized using the hydrothermal method in an autoclave. …”
    Get full text
    Get full text
  2. 1222
  3. 1223
  4. 1224
  5. 1225
  6. 1226
  7. 1227

    Bench-scale and packed bed sorption of methylene blue using treated olive pomace and charcoal by Banat, F.

    Published 2006
    “…The uptake of MB dye was significantly increased when a mixture of olive pomace and charcoal was packed in the column in a multi-layer fashion. …”
    Get full text
    Get full text
  8. 1228
  9. 1229
  10. 1230

    Enhanced performance of nano-sized SiC reinforced Al metal matrix nanocomposites synthesized through microwave sintering and hot extrusion techniques by Reddy, M. Penchal

    Published 2017
    “…In the present study, nano-sized SiC (0, 0.3, 0.5, 1.0 and 1.5 vol%) reinforced aluminum (Al) metal matrix composites were fabricated by microwave sintering and hot extrusion techniques. …”
    Get full text
    Get full text
  11. 1231
  12. 1232

    Morphology and property changes in PLA/PHBV blends as function of blend composition by Kanda G.S.

    Published 2018
    “…Both the tensile strength and Young?s modulus decreased with increasing PHBV content for the sequence of blends, and both parameters exhibited maximum values for 10?…”
    Get full text
    Get full text
  13. 1233
  14. 1234
  15. 1235
  16. 1236

    Conjugated Linoleic Acid (CLA) co-treatment alleviates antidiabetic drug, rosiglitazone associated deterioration of bone remodeling by Ibrahim, Khadega

    Published 2021
    “…Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to decreased insulin secretion, defective action or both. …”
    Get full text
    Get full text
  17. 1237

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  18. 1238
  19. 1239
  20. 1240